登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
LiCl
化学文摘社编号:
分子量:
42.39
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-212-3
MDL number:
eCl@ss:
38050203
Assay:
≥99.0% (titration)
Form:
powder
Solubility:
H2O: 1 M, clear, colorless
product line
BioXtra
Quality Level
assay
≥99.0% (titration)
form
powder
impurities
≤0.002% Phosphorus (P), ≤0.1% Insoluble matter
mp
605 °C (lit.)
solubility
H2O: 1 M, clear, colorless
anion traces
sulfate (SO42-): ≤0.01%
cation traces
Al: ≤0.0005%, Ba: ≤0.002%, Ca: ≤0.005%, Cu: ≤0.0005%, Fe: ≤0.002%, K: ≤0.005%, Mg: ≤0.005%, NH4+: ≤0.1%, Na: ≤0.005%, Pb: ≤0.001%, Zn: ≤0.001%
SMILES string
[Li+].[Cl-]
InChI
1S/ClH.Li/h1H;/q;+1/p-1
InChI key
KWGKDLIKAYFUFQ-UHFFFAOYSA-M
Application
- WDR1通过Wnt/β连环蛋白信号途径促进前列腺癌进展: 尽管该研究主要关注WDR1′在癌症中的作用,氯化锂在Wnt信号传导通路调节中的使用提供了有关其在癌症治疗中的潜在治疗应用的见解(Cheng J et al., 2024)(Cheng J et al., 2024)。
Still not finding the right product?
Explore all of our products under 氯化锂
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
存储类别
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Rosa M Leon et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 44(10), 1742-1751 (2019-04-09)
The overlap in neurobiological circuitry mediating the physiological and behavioral response to satiation and noxious/stressful stimuli are not well understood. The interaction between serotonin (5-HT) and glucagon-like peptide-1 (GLP-1) could play a role as upstream effectors involved in mediating associations
Jong Sung Kim et al.
Nature communications, 10(1), 3575-3575 (2019-08-10)
The direct sensing and storing of the information of liquids with different polarities are of significant interest, in particular, through means related to human senses for emerging biomedical applications. Here, we present an interactive platform capable of sensing and storing
Daniel I Perez et al.
Journal of medicinal chemistry, 54(12), 4042-4056 (2011-04-20)
Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| L4408-100G | 04061833957530 |
| L4408-500G | 04061838671677 |
